5+

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : eCompliance Manager

Apollo pharmacy is a leading retail chain of pharmacy and is a unit of - Apollo Hospitals Enterprise Ltd. - Asia's largest healthcare group. Our growing Retail Pharmacy network touches lives across the length and breadth of India and we serve 200000+ customers a day. With over 30 years of retailing experience, customer-focused service and brand value our network spans out to 2000+ retail pharmacies through which we have been serving our customers for their healthcare needs 24x7.*

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products).

Sanjar Pharma is a rapid growing Indian Pharmaceutical company based at Himmatnagar (Gujarat),is equipped with highly sophisticated and advanced facilities. The facility is planned and designed to meet the domestic as well as international demand both qualitatively and quantitatively. It is dedicated in manufacturing of quality sterile pharmaceutical products.

Dr. Reddy's, you will create access to medicines, for the millions who would have stayed untreated. We are the best employer in the Indian pharmaceutical industry and the 5th best among companies with over 10,000 employees. A job you pursue here is not just a job; it’s the beginning of a lifelong association.  Our culture, performance orientation and incentive structure are core differentiators that make us a preferred employer. We get the best talent onboard - whether it is sourced from within the pharmaceutical industry or outside.

Post : Analytical Scientist - 05 posts

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Regulatory Affairs Analyst for Regulatory Affairs department

Accenture is a global management consulting, technology services and outsourcing company, with approximately 275,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$28.6 billion for the fiscal year ended Aug. 31, 2013.

Post : Pharmacovigilance - Regulatory affairs

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.